Skip to Content


In the US, Fesoterodine (fesoterodine systemic) is a member of the drug class urinary antispasmodics and is used to treat Overactive Bladder and Urinary Incontinence.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Muscarinic receptor antagonist (anticholinergic, parasympatholytic agent)


Chemical Names

2-[(R)-Isobuttersäure-3-(diisopropylamino)-1-phenylpropyl]-4-(hydroxymetyl)phenylester (IUPAC)

2-[(1R)-3-(Diisopropylamino)-1-phenylpropyl]-4-(hydroxymetyl)phenylisobutyrate (WHO)

Foreign Names

  • Fesoterodinum (Latin)
  • Fesoterodin (German)
  • Fésotérodine (French)
  • Fesoterodina (Spanish)

Generic Names

  • Fesoterodine (OS: BAN)
  • SPM-907 (IS)
  • Fesoterodine Fumarate (OS: USAN, BANM, JAN)
  • SPM 8272 (IS: SchwarzPharma)
  • UNII-EOS72165S7 (IS)

Brand Names

  • Toviaz
    Pfizer, Portugal; Pfizer, Romania; Pfizer, Slovenia; Euromedicines, Spain; Farmagon, Norway; Pfizer, Austria; Pfizer, Belgium; Pfizer, Canada; Pfizer, Switzerland; Pfizer, Czech Republic; Pfizer, Germany; Pfizer, Denmark; Pfizer, Spain; Pfizer, Finland; Pfizer, United Kingdom; Pfizer, Greece; Pfizer, Hong Kong; Pfizer, Croatia (Hrvatska); Pfizer, Indonesia; Pfizer, Ireland; Pfizer, Israel; Pfizer, Iceland; Pfizer, South Korea; Pfizer, Lithuania; Pfizer, Malaysia; Pfizer, Netherlands; Pfizer, Norway; Pfizer, Philippines; Pfizer, Poland; Pfizer, Sweden; Pfizer, Slovakia; Pfizer, Turkey; Pfizer Italia, Italy; Pfizer Japan, Japan; Pfizer U.S., United States
  • Toviaz LP
    Pfizer, France


BANBritish Approved Name
BANMBritish Approved Name (Modified)
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.